NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Outset Medical, Inc. (OM) Stock Analysis

Outset Medical, Inc. (OM) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

OM

$4.05

−$0.17 (−4.03%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare OM with… →

OM Key Statistics

As of Oct 21, 2026
Trading
Open
$4.30
Previous Close
$4.22
Day's Range
3.99–4.35
52-Week Range
2.84–15.94
Volume
78.78K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.99
Valuation
Market Cap
$76.13M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.65
EPS (ttm)Profit attributable to each share over the last twelve months.
−4.00
Financials (FY)
Revenue (FY)
$119.48M+5.09%
Net Income (FY)
−$81.65M
Profit marginThe share of revenue left as profit after all costs and taxes.
−63.06%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
18.80M
1-Year Return
−73.48%
Dividend and dates
Earnings Date
November 4, 2026
Avg Volume
156.55K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, OM closed at $4.05, −73.48% over 1 year.

Outset Medical, Inc. (OM) has a market capitalization of $76.13M.

In fiscal 2025, OM reported revenue of $119.48M.

OM Stock Return by Calendar Year

Outset Medical, Inc. (OM) return since Sep 2020: what $10,000 became

1 year
$10,000 $2,652
−73.48%
5 years
$10,000 $52
−99.48%
Since Sep 2020
$10,000 $44
−99.56%

If you had invested $10,000 in Outset Medical, Inc. (OM) at the close on September 15, 2020, the earliest close on record here, it would have been worth $44 at the close on October 21, 2026: −99.56% in total, −58.86% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+9.16%
2025−77.72%
2024−79.48%
2023−79.05%
2022−43.98%
2021−18.91%
2020 (partial year)−6.33%

As of October 21, 2026.

OM Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$119.48M−$81.65M−68.3%
2024$113.69M−$127.98M−112.6%
2023$130.38M−$172.80M−132.5%
2022$115.38M−$162.96M−141.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$119.48M$46.75M−$66.71M−$81.65M−68.3%
2024$113.69M$38.56M−$113.38M−$127.98M−112.6%
2023$130.38M$29.00M−$169.77M−$172.80M−132.5%
2022$115.38M$17.83M−$161.02M−$162.96M−141.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

OM Valuation vs Medical Devices Median

Median of 145 stocks
MetricOMMedical Devices medianvs median
P/S ratio0.652.530.3x the median
Profit margin−63.06%−14.78%48.3 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Outset Medical, Inc. (OM) carries a market capitalisation of $76.13M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 310 employees.

OM last closed at $4.05 on October 21, 2026. That is −$0.17 (−4.03%) against the previous close. Over the past 52 weeks the price has ranged from $2.84 to $15.94. The latest close sits 42.56% above that 52-week low.

Financial Health

In fiscal 2025, Outset Medical, Inc. reported revenue of $119.48M. Against the prior fiscal year total of $113.69M, that is a change of +5.09%. The same year closed with a net loss of $81.65M. Profit margin runs at −63.06%. That is 48.3 percentage points below the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to −4.

Across the 4 fiscal years on file, revenue moves from $115.38M in 2022 to $119.48M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 0.65. On price-to-sales that is 0.3 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is −73.48%. Measured over 5 years, that is −65.12% a year compounded. The reported beta is 1.99. Annualized volatility over the trailing 6 years is 95.85%.

Growth & Income

The record shows no dividend for OM.

The strongest complete calendar year on file is 2021 at −18.91%; the weakest is 2024 at −79.48%. Of the 5 complete calendar years on file, 0 finished higher. So far in 2026 the total return is +9.16%.

Peer Comparison

Outset Medical, Inc. (OM) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Outset Medical, Inc. OM $76.13M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Outset Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Outset Medical, Inc.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Visit website →